Feb 2025 $9 M No. 5 $2 to $10 million 38
CND Life Sciences, Inc.: Raise no. 5, Feb 2025 × Investors in this round 38 investors had bought by the notice of May 6, 2025: 38 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $9 M of $9 M offered; $0 M still to sell
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $36,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter J. Harris · Executive Officer, Director Richard J. Morello · Executive Officer, Director Todd J. Levine · Executive Officer, Director Christopher J. Gibbons · Director Enrique J. Carrazana · Director Jack J. Seaver · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Victor Culiuc (CRD 4985575) · broker-dealer Finalis Securities (CRD 305908) · Chicago, Illinois Sold in IL Signed by Richard J. Morello, President/CEO. Source: SEC Form D and 2 amendments, newest notice filed May 6, 2025. Read the notice at the SEC .
equity SEC Mar 2024 $2 M No. 4 $2 to $10 million 22
CND Life Sciences, Inc.: Raise no. 4, Mar 2024 × Investors in this round 22 investors had bought by the notice of Mar 27, 2024: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $6 M offered; $4 M still to sell
Smallest investment taken $25,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard J. Morello · Executive Officer, Director Todd J. Levine · Executive Officer, Director Enrique J. Carrazana · Director Peter J. Harris · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard J. Morello, President/CEO. Source: SEC Form D, newest notice filed Mar 27, 2024. Read the notice at the SEC .
equity SEC Sep 2022 $5 M No. 3 $2 to $10 million 26
CND Life Sciences, Inc.: Raise no. 3, Sep 2022 × Investors in this round 26 investors had bought by the notice of Mar 24, 2023: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter J. Harris · Executive Officer, Director Richard J. Morello · Executive Officer, Director Todd J. Levine · Executive Officer, Director Enrique J. Carrazana · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard J. Morello, President/CEO. Source: SEC Form D and 1 amendment, newest notice filed Mar 24, 2023. Read the notice at the SEC .
equity SEC Oct 2021 $4 M No. 2 $2 to $10 million 22
CND Life Sciences, Inc.: Raise no. 2, Oct 2021 × Investors in this round 22 investors had bought by the notice of Nov 10, 2021: 22 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $5 M offered; $1 M still to sell
Smallest investment taken $50,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard J. Morello · Executive Officer, Director Enrique J. Carrazana · Director Peter J. Harris · Director Roy J. Freeman · Director Todd J. Levine · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard J. Morello, President. Source: SEC Form D, newest notice filed Nov 10, 2021. Read the notice at the SEC .
equity SEC Jan 2021 $3 M No. 1 $2 to $10 million 20
CND Life Sciences, Inc.: Raise no. 1, Jan 2021 × Investors in this round 20 investors had bought by the notice of Apr 28, 2021: 20 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $3 M offered
Smallest investment taken $50,000
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Richard J. Morello · Executive Officer, Director Christopher J. Gibbons · Director Peter J. Harris · Director Roy J. Freeman · Director Todd J. Levine · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Richard J. Morello, President. Source: SEC Form D, newest notice filed Apr 28, 2021. Read the notice at the SEC .
equity SEC